Picture of LumiraDx logo

LMDXF — LumiraDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

LumiraDx Ltd reports results for the quarter ended in June - Earnings Summary

* LumiraDx Ltd  LMDX.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue fell 53% to $21.00 million from a year ago;
analysts
expected $21.48 million. 
    * LumiraDx Ltd's reported EPS for the quarter was a loss
of 16
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * LumiraDx Ltd shares had fallen by 15.2% this quarter and
lost 54.8% so far this year.
    * The company reported a quarterly loss of $49.68 million.
    * Wall Street's median 12-month price target for LumiraDx
Ltd is
$1.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 24 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.14          -0.16          Missed
 Mar. 31 2023      -0.14          -0.14          Met
 Dec. 31 2022      -0.20          -0.32          Missed
 Sep. 30 2022      -0.26          -0.47          Missed

Recent news on LumiraDx

See all news